RH7.STU Ryman Healthcare Ltd

- EUR
Market cap
-
P/E
-
P/B
0.61x
ROE
-10.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2025.

Is RH7.STU undervalued?

Graham number

The Graham number of Ryman Healthcare Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ryman Healthcare Ltd fundamental analysis

No fundamental analysis for Ryman Healthcare Ltd yet.

Ryman Healthcare Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.